Aug 2026
Echocardiographic changes in right ventricular function in breast cancer patients receiving anthracycline-based chemotherapy at low cardiotoxic risk
A significant decline in right ventricular function is demonstrated during anthracycline-based cardiotoxic therapy and persisting up to one year after treatment completion, even in patients with low cardiotoxic risk, despite changes being subclinical and largely within normal ranges.
I. Gigovska Dimova, G. Petkovska, I. Ismaili et al.
· European Heart Journal, Supp... · 0 citations